Basic Stats
Insider Profile Artal Group S.A.
Portfolio Value $ 930,229,455
Current Positions 2
Latest Holdings, Performance, AUM (from 13F, 13D)

Artal Group S.A. has disclosed 2 total holdings in their latest SEC filings. Most recent portfolio value is calculated to be $ 930,229,455 USD. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Artal Group S.A.’s top holdings are CAVA Group, Inc. (US:CAVA) , and Lexicon Pharmaceuticals, Inc. (US:LXRX) .

Artal Group S.A. - Portfolio Value
Add This Fund
to your Dashboard
Top Increases This Quarter

We use the change in the portfolio allocation because this is the most meaningful metric. Changes can be due to trades or changes in share prices.

Security Shares
(MM)		 Value
(MM$)		 Portfolio % ΔPortfolio %
136.18 129.37 13.9075 6.8230
Top Decreases This Quarter

We use the change in the portfolio allocation because this is the most meaningful metric. Changes can be due to trades or changes in share prices.

Security Shares
(MM)		 Value
(MM$)		 Portfolio % ΔPortfolio %
9.51 800.86 86.0925 -6.8230
13F and Fund Filings

This form was filed on 2025-08-13 for the reporting period 2025-06-30. Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

2022-07-28: Important Note - We have changed the treatment of the Δ Portfolio % column in this table. Previously, we were reporting it as the percent change in the portfolio allocation. We are now reporting it as the raw change in the portfolio allocation (still reported as a percent). In formula terms, we were previously reporting it as 100 * (current allocation - prior allocation ) / prior allocation. We are now reporting it as (current allocation - prior allocation).
Security Type Avg Share Price Shares
(MM)		 ΔShares
(%)		 ΔShares
(%)		 Value
($MM)		 Portfolio
(%)		 ΔPortfolio
(%)
CAVA / CAVA Group, Inc. 9.51 0.00 800.86 -2.52 86.0925 -6.8230
LXRX / Lexicon Pharmaceuticals, Inc. 136.18 0.00 129.37 106.52 13.9075 6.8230